A panel of experts advising the U.S. Centers for Disease Control and Prevention on vaccines will not convene for its February ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Key CDC vaccine committee meeting pushed ...
Penmenvy combines the antigenic components of Bexsero (meningococcal Group B vaccine) and Menveo (meningococcal Groups A, C, Y, and W-135 oligosaccharide diphtheria CRM197 conjugate vaccine).
The story has been updated to correct the FDA approval date to Friday, February 14 On Friday, February 14, the FDA approved ...
Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...
At two Senate confirmation hearings, Kennedy played down his well-publicised questioning of the safety of childhood vaccines ...
GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...
CDC holds that vaccines are a safe, effective way to protect your health and prevent the spread of flu, COVID, measles. What ...